As previously reported, BofA upgraded National Vision (EYE) to Buy from Underperform with a price target of $22, up from $13, citing multiple signs that the company’s strategic initiatives begun in Q4 of 2024 are working. The firm is applying a higher multiple given its view that National Vision’s strategic initiatives have reduced downside risks and increased potential for upside against its 2026 adjusted EBITDA estimate of $192M, which is up from a prior $180M forecast.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYE: